Immunological properties of mononuclear cells from blood stem cell harvests following mobilization with erythropoietin + G-CSF in cancer patients

Cytotherapy

Volumn 2, Issue 1, 2000, Pages 15-24

  Joshi, S S ^a,c   Miller, K ^a   Jackson, J D ^b   Warkentin, P ^b   Kessinger, A ^b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Blood stem cells; Cytotoxic effector cell; Erythropoietin; Functions; G CSF; Mobilization; Phenotypes

Indexed keywords

CD14 ANTIGEN; CD20 ANTIGEN; CD3 ANTIGEN; CD56 ANTIGEN; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; ERYTHROPOIETIN; GRANULOCYTE COLONY STIMULATING FACTOR; MITOGENIC AGENT;

ADULT; ARTICLE; BIOLOGICAL THERAPY; BREAST CANCER; CANCER; CLINICAL ARTICLE; DRUG MECHANISM; FEMALE; HODGKIN DISEASE; HUMAN; HUMAN CELL; LYMPHOKINE ACTIVATED KILLER CELL; MALE; MONONUCLEAR CELL; NATURAL KILLER CELL; NONHODGKIN LYMPHOMA; OVARY CANCER; PERIPHERAL BLOOD STEM CELL; APHERESIS; BLOOD; CELL CULTURE; CELL DIVISION; CELL SIZE; CYTOLOGY; DRUG EFFECT; HEMATOPOIETIC STEM CELL; IMMUNOLOGY; IMMUNOPHENOTYPING; METHODOLOGY; MIDDLE AGED; NEOPLASM; STEM CELL MOBILIZATION;

ADULT; BLOOD COMPONENT REMOVAL; CELL DIVISION; CELL SIZE; ERYTHROPOIETIN; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOPHENOTYPING; KILLER CELLS, LYMPHOKINE-ACTIVATED; KILLER CELLS, NATURAL; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; MITOGENS; NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0034035258     PISSN: 14653249     EISSN: None     Source Type: Journal    
DOI: 10.1080/146532400539017     Document Type: Article

References (22)

1. Shpall EJ, Janes RB, Bearman SJ, Franklin WA, Berenson RJ. Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: Influence of CD34-positive peripheral blood progenitors and growth factors on engraftment. J Clin Oncol 1994;12:28-33.
2. Kessinger A, Armitage JO, Landmark JD, Smith DM, Weisenburger DD. Autologous peripheral hematopoietic stem cell transplantation restores hematopoietic function following marrow ablative therapy. Blood 1988;71:723-7.
3. Bishop MR, Anderson JR, Jackson JD, Bierman PJ, Reed EC, Vose JM, Armitage JO, Warkentin PI, Kessinger A. High dose therapy and peripheral blood progenitor cell transplantation: effects of recombinant human granulocyte-macrophage colony stimulating factor on the autograft. Blood 1994;83:610-16.
4. Bishop MR, Tarantolo SR, Jackson JD, Anderson JR, Schmit-Pokorny K, Zachrias D, Pavletic ZS, Pirruccello SJ, Vose JM, Bierman PJ, Warkentin PI, Armitage JO, Kessinger A. Allogeneic-blood stem-cell collection following mobilization with low-dose granulocyte colony-stimulating factor. J Clin Oncol 1997;15:1601-5.
5. Miller JS, Prosper F, McCullar V. Natural killer (NK) cells are functionally abnormal and NK cells are diminished in granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cell collections. Blood. 1997; 90:3098-105.
6. Joshi SS, Desler MM, Tarantolo SR, Kessinger A, Bishop MR. Decreased immune effector cells in G-CSF mobilized normal donor blood stem cell harvests. FASEB J 1999;13:A322.
7. Sloland E, Maciejewski JP, Kim S, Van Rhee F, Chaudhuri A, Barret AJ, Young NS. G-CSF alters T cell function: G-CSF decreases IFN- and increases IL-4 production by CD4 lymphocytes in culture and in vivo after stimulation of normal stem cell donor. Blood 1998;92 (suppl. 1):722a.
8. Rondelli D, Raspadori D, Anasetti C, Bandini G, Re F, Arpanati M, Stanzani M, Morelli A, Baccini C, Zaccaria A, Lemoli RM, Tura S. Alloantigen presenting capacity, T cell alloreactivity and NK function of G-CSF mobilized peripheral blood cells. Bone Marrow Transplant 1998; 22:631-7.
9. Ganser A, Bergmann M, Volkers B, Grutzmacher P, Scigalla P, Hoelzer D. In vivo effects of recombinant human erythropoietin on circulating human hematopoietic progenitor cells. Exp Hematol 1989;17:433-5.
10. Kessinger A, Bishop MR, Jackson JD, Okane-Murphy B, VoseJM, Bierman PJ, Reed EC, Warkentin PI, Armitage JO, Sharp JG. Erythropoietin for mobilization of circulating progenitor cells in patients with previously treated relapsed malignancies. Exp Hematol 1995;23:609-12.
11. Haan GD, Dontje B, Nijhof W. Concepts of hematopoietic cell amplification. Synergy, redundancy and pleiotrophy of cytokines affecting the regulation of erythropoiesis. Leuk Lymphoma 1996;22:385-94.
12. Hellstrom-Lindberg E, Kanter-Lewensohn L, Ost A. Morphological changes and apoptosis in bone marrow from patients with myelodysplastic syndromes treated with granulocyte-CSF and erythropoietin. Leuk Res 1997;21: 415-25.
13. Filip S, Vanasek J, Balah M, Vavrova J. Circulation of progenitor cells after intensive chemotherapy followed by combination G-CSF and EPO in breast carcinoma. Neoplasma 1997;44:212-18.
14. Kessinger A, Sharp JG. Mobilization of hematopoietic progenitor cells with Epoetin alfa. Semin Hematol 1996;33:(suppl 1):10-15.
15. Bishop MR, Anderson JR, Jackson JD, Bierman PJ, Reed EC, Vose JM, Armitage JO, Warkentin PI, Kessinger A. High dose therapy and peripheral blood progenitor cell transplantation: effects of recombinant human granulocyte-macrophage colony-stimulating factor on the autograft. Blood 1994;83:610-16.
16. Pierelli L, Scambia G, Menichella G, Onofrio G, Salerno G, Benedetti P, Foddai ML, Vittori M, Lai M, Cairli M, Puglia G, Mancuso S, Bizzi B. Br J Haematol 1996;92:287-94.
17. Oliveri A, Offidani M, Cinero L, Cantori I, Ombrosi L, Mancini S, Masia MC, Scalari P, Leoni P. DHAP regimen plus G-CSF as salvage therapy and priming for blood progenitor cell collection in patients with poor prognosis lymphoma. Bone Marrow Transplant 1995;16:85-93.
18. Civin CI, Strauss LC, Brovall C, Fackler MJ, Schwartz JF, Shaper JH. Antigenic analysis of hematopoiesis. Ill: a hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. J Immuuol 1984;133:157-65.
19. Verbik DJ, Jackson JD, Pirruccello SJ, Patil KD, Kessinger A, Joshi SS. Functional and phenotypic characterization of human peripheral blood stem cell harvests: a comparative analysis from consecutive collections. Blood 1995;85:1964-70.
20. Joshi SS, Messbarger LJ, Hao W. IL-2 therapy of lymphoma-bearing immunosuppressed mice. Clin Exp Metastasis 1994;12:37-43.
21. Verma UN, Yankelevich B, Hodgson J, Mazumder A. Effect of the in vivo priming regimen for peripheral blood stem cells (PBSC) mobilization on in vitro generation of cytotoxic effectors by IL-2 activation of PBSC in a murine model. Bone Marrow Transplant 1997;19:265-73.
22. Fehninger TA, Carson WE, Mrozek E, Caliguri A. Stem cell factor enhances IL-2 mediated expansion of murine natural killer cells in vivo. Blood 1997;90:3647-53.